Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 2
2012 2
2013 3
2018 3
2020 4
2021 8
2022 3
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Host extracellular vesicles confer cytosolic access to systemic LPS licensing non-canonical inflammasome sensing and pyroptosis.
Kumari P, Vasudevan SO, Russo AJ, Wright SS, Fraile-Ágreda V, Krajewski D, Jellison ER, Rubio I, Bauer M, Shimoyama A, Fukase K, Zhang Y, Pachter JS, Vanaja SK, Rathinam VA. Kumari P, et al. Among authors: shimoyama a. Nat Cell Biol. 2023 Dec;25(12):1860-1872. doi: 10.1038/s41556-023-01269-8. Epub 2023 Nov 16. Nat Cell Biol. 2023. PMID: 37973841
Limonoids with anti-inflammatory activity: A review.
Hilmayanti E, Nurlelasari, Supratman U, Kabayama K, Shimoyama A, Fukase K. Hilmayanti E, et al. Among authors: shimoyama a. Phytochemistry. 2022 Dec;204:113469. doi: 10.1016/j.phytochem.2022.113469. Epub 2022 Oct 10. Phytochemistry. 2022. PMID: 36228704 Review.
Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine.
Aso A, Nabetani H, Matsuura Y, Kadonaga Y, Shirakami Y, Watabe T, Yoshiya T, Mochizuki M, Ooe K, Kawakami A, Jinno N, Toyoshima A, Haba H, Wang Y, Cardinale J, Giesel FL, Shimoyama A, Kaneda-Nakashima K, Fukase K. Aso A, et al. Among authors: shimoyama a. Int J Mol Sci. 2023 May 12;24(10):8701. doi: 10.3390/ijms24108701. Int J Mol Sci. 2023. PMID: 37240044 Free PMC article.
TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells.
Sun X, Hosomi K, Shimoyama A, Yoshii K, Lan H, Wang Y, Yamaura H, Nagatake T, Ishii KJ, Akira S, Kiyono H, Fukase K, Kunisawa J. Sun X, et al. Among authors: shimoyama a. Int Immunopharmacol. 2023 Apr;117:109852. doi: 10.1016/j.intimp.2023.109852. Epub 2023 Feb 18. Int Immunopharmacol. 2023. PMID: 36806039 Free article.
α-Emitting cancer therapy using 211 At-AAMT targeting LAT1.
Kaneda-Nakashima K, Zhang Z, Manabe Y, Shimoyama A, Kabayama K, Watabe T, Kanai Y, Ooe K, Toyoshima A, Shirakami Y, Yoshimura T, Fukuda M, Hatazawa J, Nakano T, Fukase K, Shinohara A. Kaneda-Nakashima K, et al. Among authors: shimoyama a. Cancer Sci. 2021 Mar;112(3):1132-1140. doi: 10.1111/cas.14761. Epub 2021 Jan 22. Cancer Sci. 2021. PMID: 33277750 Free PMC article.
35 results